Indian Pharma Market Faces Q3FY25 Volume Decline Amid Pricing Gains ...Middle East

Devdiscourse - Opinion
Indian Pharma Market Faces Q3FY25 Volume Decline Amid Pricing Gains
The Indian pharmaceutical market (IPM) has experienced negative volume growth in the third quarter of fiscal year 2025 after two successive quarters of modest gains, according to a report by Goldman Sachs. Despite this downturn, the market's performance has been buoyed by a robust 5.3% year-on-year rise in pricing and a 2.6% growth stemming from new product launches following recent patent expirations.

Hence then, the article about indian pharma market faces q3fy25 volume decline amid pricing gains was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indian Pharma Market Faces Q3FY25 Volume Decline Amid Pricing Gains )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Opinion


Latest News
before 15 hour & 36 minute